While the rest of the Chinese stock market dropped more than 4 per cent on Wednesday, the most talked about initial public offering of the month managed a surge of 18.4 per cent on its trading debut, helping the country's richest couple get a little bit richer.
Shenzhen Hepalink Pharmaceutical finished its first day of trading on the Shenzhen stock exchange at Rmb175.17 per share, well up from its IPO price of Rmb148, which was already the most expensive IPO valuation ever in modern China.
The rich IPO valuation catapulted Li Li and his wife Li Tan, Hepalink's founders and majority shareholders, from obscurity to become the richest people in China overnight last week.
您已閱讀55%（674字），剩餘45%（556字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。